Enterprise Value

-4.638M

Cash

6.475M

Avg Qtr Burn

-2.513M

Short % of Float

1.17%

Insider Ownership

0.63%

Institutional Own.

3.94%

Qtr Updated

03/31/24


Drug Pipeline

Powered by

Only showing assets and stage. See catalyst data with a free or premium account. Unlock more data with a free account.

Drug & IndicationStage & EventCatalyst Date
PH-762 Details
Cutaneous squamous cell carcinoma, Melanoma, Metastatic merkel cell carcinoma, Cancer

Phase 1b

Update